Sign In
Buy GSK
$51.46
-0.0700 (-0.136%)
At Close: Aug 05, 2026
Forget the Fed. These 3 Stocks Will Soar No Matter What
06:19am, Monday, 29'th Apr 2024
Few experts expect the U.S. Federal Reserve to raise interest rates this year. And Fed Chairman Jerome Powell still has not ruled out the possibility of the central bank cutting rates in 2024.
Why the Market Dipped But GSK (GSK) Gained Today
07:21pm, Thursday, 25'th Apr 2024
In the most recent trading session, GSK (GSK) closed at $40.91, indicating a +0.12% shift from the previous trading day.
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
09:40am, Thursday, 25'th Apr 2024
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-1
GSK (GSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:08am, Wednesday, 24'th Apr 2024
Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GSK Gears Up for Q1 Earnings: Here's What to Expect
02:21pm, Tuesday, 23'rd Apr 2024
We expect GSK's specialty products like Arexvy, Cabenuva, Juluca, Dovato, Nucala, Trelegy Ellipta and Shingrix to drive first-quarter sales performance.
Why the Market Dipped But GSK (GSK) Gained Today
07:20pm, Friday, 19'th Apr 2024
In the latest trading session, GSK (GSK) closed at $39.75, marking a +1.22% move from the previous day.
Why GSK (GSK) is a Top Value Stock for the Long-Term
10:46am, Wednesday, 17'th Apr 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
GSK Announces FDA Acceptance of New Meningococcal Jab BLA
09:16am, Wednesday, 17'th Apr 2024
The approval of GSK's 5-in-1 meningococcal ABCWY vaccine candidate, MenABCWY, could provide the broadest meningococcal serogroup coverage and lead to simplified immunization.
GSK encouraged by Shingles and Gonorrhoea trials
04:11am, Wednesday, 17'th Apr 2024
GSK has delivered encouraging updates from ongoing trials of its vaccines for Shingles and Gonorrhoea. In the follow-up Zoster trial for the now on-sale Shingrix vaccine, efficacy was more than 80% fo
GSK says efficacy of its shingles vaccine remains high after years
02:20am, Wednesday, 17'th Apr 2024
British drugmaker GSK said on Wednesday long-term data showed that its blockbuster shingles vaccine, Shingrix, had 79.7% efficacy in participants aged 50 years and above, six to 11 years after vaccina
GSK (GSK) Rises But Trails Market: What Investors Should Know
06:56pm, Thursday, 11'th Apr 2024
GSK (GSK) closed at $40.80 in the latest trading session, marking a +0.27% move from the prior day.
GSK (GSK) Rises Yet Lags Behind Market: Some Facts Worth Knowing
07:06pm, Friday, 05'th Apr 2024
GSK (GSK) concluded the recent trading session at $41.19, signifying a +0.81% move from its prior day's close.
GSK (GSK) Registers a Bigger Fall Than the Market: Important Facts to Note
07:21pm, Tuesday, 02'nd Apr 2024
GSK (GSK) concluded the recent trading session at $41.79, signifying a -1.49% move from its prior day's close.
GSK PLC Sponsored ADR (GSK) is Attracting Investor Attention: Here is What You Should Know
10:01am, Thursday, 28'th Mar 2024
Recently, Zacks.com users have been paying close attention to Glaxo (GSK). This makes it worthwhile to examine what the stock has in store.
Here's Why GSK (GSK) Gained But Lagged the Market Today
07:05pm, Wednesday, 27'th Mar 2024
GSK (GSK) closed at $42.99 in the latest trading session, marking a +0.47% move from the prior day.
